As illustrated in Fig. 4d and e, inhibition of KDM4C with shRNAs or SD70 treatment reduced the basal expression levels of TGF-β2, BMP2 and JUND while increasing the expression level of GDF11 in lung cancer cells. Here, TGFB2 is linked to lung cancer.